Table 1.

Baseline demographic and clinical data of included patients.

Characteristic	Patient’s Data
Sex, n (%)	60 (100)
Female	41 (68.3)
Male	19 (31.7)
Age (years)
Mean (SD)	77.35 ± 6.41
Median (range)	78 (63–94)
Mean time from diagnosis to anti-VEGF treatment (weeks)
Mean (SD)	2.95 ± 1.95
Median (range)	2.50 (1–8)
Mean time from start of nAMD treatment to cataract surgery (months)
Mean (SD)	28.98 ± 20.89
Median (range)	23.50 (6–96)

Abbreviations: anti-VEGF, anti-vascular growth endothelial factor; nAMD, neovascular age-related macular degeneration; SD, standard deviation.